Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Kidney Cancer market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Kidney Cancermarket, defines the market attractiveness level of Kidney Cancer market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Kidney Cancer industry, describes the types of Kidney Cancer market, the applications of major players and the market size, and deeply analyzes the current situation of the global Kidney Cancer market and the development prospects and opportunities of Kidney Cancer industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Kidney Cancer market in Chapter 13.
By Player:
Novartis
Exelixis
Bayer
Eisai
Pfizer
Bristol-Myers Squibb
By Type:
Renal Cell Carcinoma (RCC)
Transitional Cell Carcinoma (TCC)
By End-User:
Surgery
Immunotherapy
Chemotherapy
Radiation
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Kidney Cancer Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Kidney Cancer Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Kidney Cancer Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Kidney Cancer Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Kidney Cancer Market Analysis and Outlook to 2022
-
7.1 Global Kidney Cancer Consumption (2017-2022)
-
7.2 United States Kidney Cancer Consumption (2017-2022)
-
7.3 Europe Kidney Cancer Consumption (2017-2022)
-
7.4 China Kidney Cancer Consumption (2017-2022)
-
7.5 Japan Kidney Cancer Consumption (2017-2022)
-
7.6 India Kidney Cancer Consumption (2017-2022)
-
7.7 South Korea Kidney Cancer Consumption (2017-2022)
8 Region and Country-wise Kidney Cancer Market Analysis and Outlook to 2028
-
8.1 Global Kidney Cancer Consumption Forecast (2022-2028)
-
8.2 United States Kidney Cancer Consumption Forecast (2022-2028)
-
8.3 Europe Kidney Cancer Consumption Forecast (2022-2028)
-
8.4 China Kidney Cancer Consumption Forecast (2022-2028)
-
8.5 Japan Kidney Cancer Consumption Forecast (2022-2028)
-
8.6 India Kidney Cancer Consumption Forecast (2022-2028)
-
8.7 South Korea Kidney Cancer Consumption Forecast (2022-2028)
9 Global Kidney Cancer Market Outlook by Types and Applications to 2022
-
9.1 Global Kidney Cancer Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Renal Cell Carcinoma (RCC) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Transitional Cell Carcinoma (TCC) Consumption and Growth Rate (2017-2022)
-
9.2 Global Kidney Cancer Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Surgery Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Radiation Consumption and Growth Rate (2017-2022)
10 Global Kidney Cancer Market Outlook by Types and Applications to 2028
-
10.1 Global Kidney Cancer Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Renal Cell Carcinoma (RCC) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Transitional Cell Carcinoma (TCC) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Kidney Cancer Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Radiation Consumption Forecast and Growth Rate (2022-2028)
11 Global Kidney Cancer Import and Export Analysis (Top 5 Countries)
-
11.1 Global Kidney Cancer Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Kidney Cancer Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Kidney Cancer Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Kidney Cancer Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Kidney Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Kidney Cancer Product and Service
-
14.2 Exelixis
-
14.2.1 Exelixis Company Details
-
14.2.2 Exelixis Kidney Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Exelixis Kidney Cancer Product and Service
-
14.3 Bayer
-
14.3.1 Bayer Company Details
-
14.3.2 Bayer Kidney Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer Kidney Cancer Product and Service
-
14.4 Eisai
-
14.4.1 Eisai Company Details
-
14.4.2 Eisai Kidney Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eisai Kidney Cancer Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Kidney Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Kidney Cancer Product and Service
-
14.6 Bristol-Myers Squibb
-
14.6.1 Bristol-Myers Squibb Company Details
-
14.6.2 Bristol-Myers Squibb Kidney Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bristol-Myers Squibb Kidney Cancer Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Kidney Cancer
-
Figure Kidney Cancer Picture
-
Table Global Kidney Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney Cancer Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Kidney Cancer Consumption by Country (2017-2022)
-
Figure United States Kidney Cancer Consumption and Growth Rate (2017-2022)
-
Table Europe Kidney Cancer Consumption and Growth Rate (2017-2022)
-
Figure China Kidney Cancer Consumption and Growth Rate (2017-2022)
-
Figure Japan Kidney Cancer Consumption and Growth Rate (2017-2022)
-
Figure India Kidney Cancer Consumption and Growth Rate (2017-2022)
-
Figure South Korea Kidney Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Cancer Consumption Forecast by Country (2022-2028)
-
Figure United States Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renal Cell Carcinoma (RCC) Consumption and Growth Rate (2017-2022)
-
Figure Global Transitional Cell Carcinoma (TCC) Consumption and Growth Rate (2017-2022)
-
Figure Global Surgery Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Radiation Consumption and Growth Rate (2017-2022)
-
Figure Global Renal Cell Carcinoma (RCC) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Transitional Cell Carcinoma (TCC) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiation Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Kidney Cancer Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Kidney Cancer Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Kidney Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Kidney Cancer Product and Service
-
Table Exelixis (Foundation Year, Company Profile and etc.)
-
Table Exelixis Kidney Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Exelixis Kidney Cancer Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Kidney Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Kidney Cancer Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Kidney Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Kidney Cancer Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Kidney Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Kidney Cancer Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Kidney Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Kidney Cancer Product and Service
-
